In this section
@article{Caramori:2004,
author = {Caramori, G and Adcock, IM and Ito, K},
journal = {Curr Opin Investig Drugs},
pages = {1141--1147},
title = {Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD.},
url = {https://www.ncbi.nlm.nih.gov/pubmed/15573863},
volume = {5},
year = {2004}
}
TY - JOUR
AB - Nuclear factor-kappaB (NFkappaB) is an inducible transcription factor that plays a central role in the regulation of many immune and inflammatory responses. While NFkappaB is required for cell survival and immunity, abnormal expression and/or activation of NFkappaB leads to the development of many pathological states, especially those involved in chronic and acute inflammation. Many different signal transduction pathways, originating from a wide variety of cellular stresses and stimuli, converge on a single target; the NFkappaB/IkappaB complex and its activating kinase (inhibitor of kappaB kinase, IKK). Here, we review some of the major NFkappaB activating pathways, their role in the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD), and their potential as targets in the treatment of asthma and COPD.
AU - Caramori,G
AU - Adcock,IM
AU - Ito,K
EP - 1147
PY - 2004///
SN - 1472-4472
SP - 1141
TI - Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD.
T2 - Curr Opin Investig Drugs
UR - https://www.ncbi.nlm.nih.gov/pubmed/15573863
VL - 5
ER -
For any enquiries about the Fungal Science Network at Imperial, please contact: